{"id":"W2161512169","doi":"10.1177/1352458514557986","title":"Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Prothena; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Sanofi","keywords":"Medicine; Dosing; Placebo; Regimen; Internal medicine; Multiple sclerosis; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002526919,0.00081626,0.001537072,0.0007849169,0.0006915895,0.0003405548,0.0008540024,0.00036653,0.0003188897],"category_scores_gemma":[0.008033819,0.0007130624,0.0006201582,0.0007923209,0.0004739606,0.000765536,0.0004973146,0.002220609,0.0005152694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000762821,"about_ca_system_score_gemma":0.0001790356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009364075,"about_ca_topic_score_gemma":0.001306251,"domain_scores_codex":[0.992412,0.0006719529,0.002019429,0.001342012,0.001783469,0.001771149],"domain_scores_gemma":[0.9940442,0.002191099,0.0006779786,0.001347732,0.0006612209,0.001077779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01340798,0.002022743,0.5091831,0.0001438661,0.0006718517,0.00007646633,0.004750553,0.001503141,0.3275389,0.00002812991,0.0159557,0.1247175],"study_design_scores_gemma":[0.03351022,0.0009205381,0.9192493,0.002919034,0.000106406,0.00003314401,0.001061382,0.0119512,0.01418624,0.00005432198,0.01524192,0.000766297],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873511,0.001077274,0.001571996,0.005494253,0.00108114,0.001099228,0.0003648031,0.0002380138,0.001722224],"genre_scores_gemma":[0.9794822,0.003471088,0.01399319,0.0006834051,0.001678436,0.0001124984,0.0001184338,0.0001602321,0.0003004734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4100662,"threshold_uncertainty_score":0.999532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1245822529333655,"score_gpt":0.2962346911310162,"score_spread":0.1716524381976507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}